TP53 and esophageal squamous cell carcinoma: Metastatic ESCCs harbor frequent TP53, KMT2D, ZNF750 and IRF5 mutations; among these mutations, ZNF50 mutations were clearly more frequent in ESCC with lymph node metastasis than in those without metastasis [58].